Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ASTRAZENECA PLC Hits Price Target Forecast with 19.02% Profit

April 25, 2024
QuantWave, the automated forecasting platform, successfully predicted a long signal for ASTRAZENECA PLC on December 5, 2023, when the stock was trading at $61.77. The forecast indicated a positive movement, and on April 25, 2024, the target price of $73.52 was achieved, resulting in a profit of 19.02%.

This successful forecast for ASTRAZENECA PLC showcases the accuracy and reliability of QuantWave's analytics in predicting stock movements. The positive outcome is a testament to the platform's capabilities in providing valuable insights to investors.

Market analysis suggests that various factors contributed to the stock's upward trajectory, including strong financial performance, developments in its pipeline, and positive industry trends. These favorable conditions aligned with QuantWave's forecast, leading to the successful price target achievement.

QuantWave offers users access to predictions for a wide range of stocks, presenting opportunities for potential profits. Investors seeking to enhance their investment strategy can benefit from QuantSchool, which offers comprehensive educational resources on utilizing the QuantWave forecasting system. QuantSchool provides key principles for generating consistent income, empowering investors to make informed decisions based on quantitative analysis and data-driven insights.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNJune 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know  ~1 min.

AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....


AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....


AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....


AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....


AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....


AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....


AZNMarch 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy  ~2 min.

ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....


AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....


AZNFebruary 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....


AZNFebruary 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....


AZNAugust 15, 2024Achievement of Price Target Forecast for AstraZeneca PLC Generates Profit of 30.9%  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a price target for AstraZeneca PLC on October 3, 2023. The forecast indicated a long position with the stock priced at $63.95....


AZNAugust 27, 2024ASTRAZENECA PLC Hits QuantWave Forecast Target with 28.17% Profit  ~1 min.

On August 15, 2023, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.08 $. This prediction proved to be accurate as on August 27, 2024, the stock reached the target price of 85....


AZNNovember 13, 2024AstraZeneca Plc AZN boosts 2024 forecast after successful Q3 earnings call  ~2 min.

AstraZeneca Plc (AZN) recently announced its impressive Q3 2024 earnings during the company's earnings call....


AZNJanuary 1, 2025Is AZN AstraZeneca PLC Among the U.K. Dividend Champions for 2024?  ~1 min.

AstraZeneca PLC (AZN) has been making waves in the pharmaceutical industry with its cutting-edge treatments and innovative research....


AZNMay 1, 2024ASTRAZENECA PLC Hits Price Target Forecast with 15.33% Profit, Showcasing the Accuracy of QuantWave's Analytics  ~2 min.

ASTRAZENECA PLC has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 15.33%. The forecast signal was given on January 16, 2024, with the stock priced at 64.92 $....